BRIEF-Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing

Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc.

NEUP

0.00

July 23 (Reuters) - Neuphoria Therapeutics Inc NEUP.O:

  • SCANCELL AND NEUPHORIA THERAPEUTICS ANNOUNCE MERGER AGREEMENT AND FINANCING

  • SCANCELL AND NEUPHORIA THERAPEUTICS ANNOUNCE MERGER AGREEMENT AND FINANCING

  • NEUPHORIA THERAPEUTICS - SCANCELL TO BUY NEUPHORIA IN ALL-SHARE MERGER

  • NEUPHORIA THERAPEUTICS - SCANCELL EXPECTS TO SECURE UP TO $89 MILLION IN FINANCING

  • NEUPHORIA THERAPEUTICS - SCANCELL SHAREHOLDERS TO OWN 85.5%, NEUPHORIA SHAREHOLDERS 14.5% OF COMBINED COMPANY

Source text: ID:nGNX50mbrP

Further company coverage: NEUP.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.